Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion

BACKGROUND: Most patients with advanced prostate cancer develop bone metastases, which often result in painful and debilitating skeletal-related events. Inhibitors of bone resorption, such as bisphosphonates and denosumab, can each reduce the incidence of skeletal-related events and delay the progre...

Descripción completa

Detalles Bibliográficos
Autores principales: Body, Jean-Jacques, von Moos, Roger, Niepel, Daniela, Tombal, Bertrand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148993/
https://www.ncbi.nlm.nih.gov/pubmed/30236112
http://dx.doi.org/10.1186/s12894-018-0393-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148993/
https://www.ncbi.nlm.nih.gov/pubmed/30236112
http://dx.doi.org/10.1186/s12894-018-0393-9

Ejemplares similares